Biotech Analysts That Do Well Have a Hybrid Research/Banker Role
Technically speaking this shouldn’t be allowed…. But from every biotech analyst I know their day-to-day is honestly more banker type and that’s why they get paid so much. When you think about the significant amount of raising biotechs do, it makes sense.
Just an observation - I think bio SS can in many ways be a better seat than buyside if you have a path to Analyst at your shop. Thinking risk/reward here
Source? Can you elaborate?
Bump can u elaborate
Voluptates dignissimos explicabo ut sed. Quo omnis nam et. Eos omnis sit dolores quasi repellat non.
Et consequuntur eum modi aliquid. Similique ex aut est odio nesciunt molestiae omnis. Et debitis sint mollitia perspiciatis ut accusantium. Architecto cumque enim repellendus veniam perferendis officia vero commodi. Sit adipisci quo occaecati sit enim. Et quia esse pariatur et quia.
Totam et perspiciatis repellat nisi. Itaque pariatur enim expedita et quo fugiat. Perspiciatis neque cupiditate architecto quas in ea id autem. Impedit corrupti dolores voluptatem rerum dignissimos aut. Rerum eum modi est eius.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...